• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估海湾合作委员会国家中聚焦于卫生经济学和药物经济学的文献数量与质量。

Evaluating quantity and quality of literature focusing on health economics and pharmacoeconomics in Gulf Cooperation Council countries.

作者信息

Eljilany Islam, El-Dahiyat Faris, Curley Louise Elizabeth, Babar Zaheer-Ud-Din

机构信息

a Independent Researcher , Pharmacoeconomics Expert , Qatar.

b College of Pharmacy , Al Ain University of Science and Technology , Al Ain , United Arab Emirates.

出版信息

Expert Rev Pharmacoecon Outcomes Res. 2018 Aug;18(4):403-414. doi: 10.1080/14737167.2018.1479254. Epub 2018 May 30.

DOI:10.1080/14737167.2018.1479254
PMID:29779401
Abstract

BACKGROUND

The importance of pharmacoeconomics and health economics has been augmented. It has the potential to provide evidence to aid in optimal decision-making in the funding of cost-effective medicines and services in Gulf Cooperation Council countries (G.C.C).

OBJECTIVE

To evaluate the quality and quantity of health economic researches published until the end of 2017 in G.C.C. and to identify the factors that affect the quality of studies.

METHOD

Studies were included according to predefined inclusion and exclusion criteria. The quantity was recorded, and the quality was assessed using the Quality of Health Economic Studies (QHES) instrument.

RESULTS

Forty-nine studies were included. The mean (SD) quality score of all studies was 57.83 (25.05), and a high number of reviewed studies (47%) were evaluated as either poor or extremely poor quality. The factors that affect the quality of studies with statistical significance were, the type and method of economic evaluation, the economic outcome was the objective of the research, author`s background, the perspective of the study, health intervention and source of funding.

CONCLUSION

The use of economic evaluation studies in G.C.C was limited. Different factors that affect the quality of articles such as performing a full economic evaluation and choosing societal perspective were identified. Strategies to improve the quality of future studies were recommended.

摘要

背景

药物经济学和卫生经济学的重要性已得到增强。它有可能为海湾合作委员会国家(G.C.C)具有成本效益的药品和服务的资金分配提供最佳决策依据。

目的

评估截至2017年底在G.C.C发表的卫生经济研究的质量和数量,并确定影响研究质量的因素。

方法

根据预先定义的纳入和排除标准纳入研究。记录数量,并使用卫生经济研究质量(QHES)工具评估质量。

结果

纳入了49项研究。所有研究的平均(标准差)质量得分为57.83(25.05),且大量被审查的研究(47%)被评估为质量差或极差。具有统计学意义的影响研究质量的因素包括经济评价的类型和方法、经济结果是研究目的、作者背景、研究视角、卫生干预措施和资金来源。

结论

G.C.C对经济评价研究的使用有限。确定了影响文章质量的不同因素,如进行全面的经济评价和选择社会视角。建议了提高未来研究质量的策略。

相似文献

1
Evaluating quantity and quality of literature focusing on health economics and pharmacoeconomics in Gulf Cooperation Council countries.评估海湾合作委员会国家中聚焦于卫生经济学和药物经济学的文献数量与质量。
Expert Rev Pharmacoecon Outcomes Res. 2018 Aug;18(4):403-414. doi: 10.1080/14737167.2018.1479254. Epub 2018 May 30.
2
Evaluation and Characterization of Health Economics and Outcomes Research in SAARC Nations.南亚区域合作联盟国家卫生经济学与结果研究的评估与特征分析
Ther Innov Regul Sci. 2018 May;52(3):348-353. doi: 10.1177/2168479017731583. Epub 2017 Sep 25.
3
[Evaluation of the quality of the websites of pharmacoeconomics and health economics centers through a validated questionnaire].[通过一份经过验证的问卷评估药物经济学和卫生经济学中心网站的质量]
Gac Sanit. 2004 Jul-Aug;18(4):295-304. doi: 10.1016/s0213-9111(04)72016-6.
4
The state of health economic research in South Africa: a systematic review.南非健康经济研究状况:系统评价。
Pharmacoeconomics. 2012 Oct 1;30(10):925-40. doi: 10.2165/11589450-000000000-00000.
5
Examining the value and quality of health economic analyses: implications of utilizing the QHES.审视卫生经济分析的价值与质量:运用卫生经济与结果研究质量工具(QHES)的影响
J Manag Care Pharm. 2003 Jan-Feb;9(1):53-61. doi: 10.18553/jmcp.2003.9.1.53.
6
Assessing the Quality of Economic Evaluations of FDA Novel Drug Approvals: A Systematic Review.评估美国食品药品监督管理局新型药物批准的经济学评价质量:一项系统评价。
Ann Pharmacother. 2016 Dec;50(12):1028-1040. doi: 10.1177/1060028016662893. Epub 2016 Aug 2.
7
Pharmacoeconomics.药物经济学
Natl Med J India. 2004 Mar-Apr;17(2):80-3.
8
Barriers and facilitators to conducting economic evaluation studies of Gulf Cooperation Council (GCC) countries: a survey of researchers.海湾合作委员会(GCC)国家开展经济评估研究的障碍与促进因素:一项对研究人员的调查
Health Res Policy Syst. 2021 May 1;19(1):71. doi: 10.1186/s12961-021-00721-1.
9
The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.ISPOR 成本效益研究质量改进良好实践工作组报告。
Value Health. 2009 Nov-Dec;12(8):1086-99. doi: 10.1111/j.1524-4733.2009.00605.x. Epub 2009 Sep 10.
10
A Systematic Review on the Extent and Quality of Pharmacoeconomic Publications in Egypt.埃及药物经济学文献的范围和质量的系统评价。
Clin Drug Investig. 2019 Feb;39(2):157-168. doi: 10.1007/s40261-018-0730-5.

引用本文的文献

1
Assessment and predictive analysis of health professions students' proficiency in health economics and pharmacoeconomics in Southwest China: a cross-sectional study.中国西南地区卫生职业学生卫生经济学和药物经济学能力评估及预测分析:一项横断面研究。
BMC Med Educ. 2024 Oct 31;24(1):1239. doi: 10.1186/s12909-024-06214-3.
2
Characteristics and Quality Appraisal of the Economic Evaluations Done in Ethiopia: A Systematic Review.埃塞俄比亚经济评估的特征与质量评估:一项系统综述
Pharmacoecon Open. 2023 Nov;7(6):877-886. doi: 10.1007/s41669-023-00433-y. Epub 2023 Aug 25.
3
Health Economic Publications From the Middle East and North Africa Region: A Scoping Review of the Volume and Methods of Research.
中东和北非地区的卫生经济出版物:研究数量与方法的范围综述
Glob J Qual Saf Healthc. 2020 Jun 8;3(2):44-54. doi: 10.36401/JQSH-20-4. eCollection 2020 May.
4
Attitude and perception of pharmacists and healthcare professionals about the criteria used in drug formulary selection in the United Arab Emirates.阿联酋药剂师和医疗保健专业人员对药品处方集选择标准的态度和看法。
J Pharm Policy Pract. 2022 Oct 18;15(1):67. doi: 10.1186/s40545-022-00460-w.
5
Barriers and Facilitators of Pharmacoeconomic Studies: A Review of Evidence from the Middle Eastern Countries.药物经济学研究的障碍和促进因素:来自中东国家的证据综述。
Int J Environ Res Public Health. 2022 Jun 27;19(13):7862. doi: 10.3390/ijerph19137862.
6
Pharmacy practice and clinical pharmacy research in the Middle East: a scoping review of studies from Bahrain, Iraq, Jordan, Kuwait, Lebanon, Oman, Palestine, Qatar, Saudi Arabia, Syria, United Arab Emirates, and Yemen.中东地区的药学实践与临床药学研究:对来自巴林、伊拉克、约旦、科威特、黎巴嫩、阿曼、巴勒斯坦、卡塔尔、沙特阿拉伯、叙利亚、阿拉伯联合酋长国和也门的研究进行的范围综述
J Pharm Policy Pract. 2022 Jun 8;15(1):40. doi: 10.1186/s40545-022-00434-y.
7
Disease-Related Costs Published in The Middle East and North Africa Region: Systematic Review and Analysis of Transferability.中东和北非地区发表的疾病相关费用:系统评价和可转移性分析。
Pharmacoeconomics. 2022 Jun;40(6):587-599. doi: 10.1007/s40273-022-01146-6. Epub 2022 May 17.
8
A Systematic Review on Economic Evaluation Studies of Diagnostic and Therapeutic Interventions in the Middle East and North Africa.中东和北非地区诊断与治疗干预措施经济评估研究的系统评价
Appl Health Econ Health Policy. 2022 May;20(3):315-335. doi: 10.1007/s40258-021-00703-y. Epub 2021 Dec 21.
9
A Systematic Review of Sources of Outcomes and Cost Data Utilized in Economic Evaluation Research Conducted in the Gulf Cooperation Council.对海湾合作委员会开展的经济评估研究中所使用的结果和成本数据来源的系统评价。
Risk Manag Healthc Policy. 2021 Jan 20;14:209-220. doi: 10.2147/RMHP.S285359. eCollection 2021.
10
Capacity for health economics research and practice in Jordan, Lebanon, the occupied Palestinian territories and Turkey: needs assessment and options for development.约旦、黎巴嫩、巴勒斯坦被占领土及土耳其的卫生经济学研究与实践能力:需求评估与发展选项
Health Res Policy Syst. 2020 Sep 3;18(1):99. doi: 10.1186/s12961-020-00586-w.